• About
  • Masthead
  • License Content
  • Advertise
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Gastroenterology

Dietary interventions have small effect on autism symptoms

byMichael DinhandLeah Carr, MD
October 4, 2019
in Gastroenterology, Neurology, Pediatrics, Psychiatry
Reading Time: 3 mins read
Quick Take: Association of Prenatal Exposure to Air Pollution with Autism Spectrum Disorder
Share on FacebookShare on TwitterShare on LinkedIn

1. A meta-analysis of studies evaluating dietary interventions used in treatment of autism spectrum disorder (ASD) in children found that omega-3, vitamin supplementation, and other supplementations were more effective than placebo in treating a number of ASD symptoms.

2. All types of dietary interventions had small effect sizes relative to placebo, as well as low statistical heterogeneity and low risk of publication bias.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Dietary and nutritional interventions are used by many families to treat ASD. However, evidence for the efficacy of most of these interventions remains limited and controversial. In this meta-analysis, researchers used study-level data from 27 randomized clinical trials studies to examine the effect of dietary intervention on an array of symptom groups in subjects with ASD. The meta-analysis revealed that dietary supplementation, including omega-3 and vitamin supplementation, was significantly more effective than placebo in treating a number of clinical domains, including anxiety, behavioral problems and impulsivity, and restricted and repetitive behaviors. These relationships were all of small effect sizes relative to placebo.

These findings are limited by the methodologic heterogeneity of the studies, which varied in intervention dose, outcome measures, follow-up time, and sample characteristics. Furthermore, most of the included studies did not assess the presence of baseline nutritional deficits. Nonetheless, the study is strengthened by its extensive meta-analysis of a large aggregated sample. For physicians, these findings suggest that there is little evidence to support the use of nonspecific dietary interventions in children with ASD, although there may be some benefits from a number of specific dietary interventions.

Click to read the study, published today in Pediatrics

RELATED REPORTS

Children with intellectual and developmental disabilities have increased risks of depression and anxiety

A machine-learning diet score identifies eating patterns associated with lower aging-related mortality

Click to read an accompanying commentary in Pediatrics

Relevant reading: A Systematic Review and Meta-Analysis of Comprehensive Interventions for Pre-School Children with Autism Spectrum Disorder (ASD)

In-Depth [meta-analysis]: Researchers used publication databases to identify 2283 records of placebo-controlled, double-blind, randomized clinical trials published from database inception to September 2017 that examined the effectiveness of dietary interventions on 17 symptom groups relating to ASD. Studies were included if they were published in English, had at least 5 subjects in the ASD intervention group, and included individuals diagnosed with ASD, pervasive development disorder, or Asperger syndrome. They conducted a meta-analysis using study-level data from 27 studies, comprising a total sample of 1028 subjects with ASD, to calculate Hedges’ adjusted g values* as estimates of effect size of dietary intervention relative to placebo.

Meta-analyses revealed that dietary supplementation (omega-3, vitamin supplementation, and/or other supplementation) was more effective than placebo in treating a number of clinical domains and symptoms, including anxiety (Hedges’ g = 0.482, 95% confidence interval [CI] 0.167-0.797), behavioral problems and impulsivity (Hedges’ g = 0.482, 95%CI 0.242-0.721), and restricted and repetitive behaviors (Hedges’ g = 0.269, 95%CI 0.106-0.432). All types of dietary intervention had small effect sizes relative to placebo, as well as low statistical heterogeneity and low risk of publication bias.

*Hedges’ g is a measure of effect size that incorporates the difference in means between groups and the pooled and weighted standard deviation. A g of 1 indicates the 2 groups differ by 1 standard deviation.

Image: PD

©2019 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: anxietyautism spectrum disorderdietimpulsivity
Previous Post

#VisualAbstract: Blood Culture Results Before and After Antimicrobial Administration in Patients With Severe Manifestations of Sepsis

Next Post

#VisualAbstract: Five-Year Outcomes of a Randomized Trial of Treatments for Varicose Veins

RelatedReports

A young boy studying at a desk with books and a contrasting image of an adult man walking outdoors, symbolizing the life course from childhood to adulthood.
Pediatrics

Children with intellectual and developmental disabilities have increased risks of depression and anxiety

October 14, 2026
A healthcare professional contemplates while surrounded by images of a human silhouette, a hospital, and a physician interacting with a child and parent, indicating pediatric care.
Longevity

A machine-learning diet score identifies eating patterns associated with lower aging-related mortality

October 1, 2026
A man sits pensively by a window with a depiction of a synapse illustrating neurotransmitter activity, suggesting a focus on mental health treatment mechanisms.
Artificial Intelligence

Artificial intelligence (AI) chatbot reduced depression, anxiety, and eating disorder risk symptoms

September 11, 2026
Weekly Rewinds

2 Minute Medicine Rewind June 29, 2026

June 29, 2026
Next Post
#VisualAbstract: Five-Year Outcomes of a Randomized Trial of Treatments for Varicose Veins

#VisualAbstract: Five-Year Outcomes of a Randomized Trial of Treatments for Varicose Veins

Transthoracic echocardiography can rule out endocarditis in low-risk bacteremic patients

Vitamin C may not provide benefit in sepsis with acute respiratory failure

Many new pediatric asthma cases attributable to obesity

Quick Take: Use of fenofibrate on cardiovascular outcomes in statin users with metabolic syndrome

✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Induction with remimazolam (Byfavo) for patients undergoing laparoscopic gastrointestinal surgery may reduce post-operative delirium compared with propofol
  • 2 Minute Medicine Rewind October 19, 2026
  • Deep learning model demonstrates potential to generate an interpretable brain health biomarker from sleep electroencephalography
License Content
Terms of Use | Disclaimer
Cookie Policy
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.